SoftOx Solutions AS (OSL:SOFTX)
0.0890
-0.0018 (-1.98%)
At close: Aug 3, 2026
SoftOx Solutions AS Market Cap
SoftOx Solutions AS has a market cap or net worth of 233.12 million as of August 4, 2026. Its market cap has increased by 3.53% in one year.
Market Cap
233.12M
Enterprise Value
213.52M
Revenue
16.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since June 1, 2018, SoftOx Solutions AS's market cap has increased from 124.04M to 233.12M, an increase of 87.95%. That is a compound annual growth rate of 8.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 233.12M | 11.07% |
| Dec 30, 2025 | 209.88M | 668.29% |
| Dec 30, 2024 | 27.32M | -18.48% |
| Dec 29, 2023 | 33.51M | -86.09% |
| Dec 30, 2022 | 240.99M | -57.32% |
| Dec 30, 2021 | 564.67M | -7.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thor Medical ASA | 2.08B |
| Circio Holding ASA | 1.95B |
| Nykode Therapeutics AS | 1.10B |
| ArcticZymes Technologies ASA | 1.00B |
| Zelluna ASA | 664.75M |
| Lytix Biopharma ASA | 653.65M |
| Oncoinvent ASA | 367.23M |
| Arctic Bioscience AS | 71.97M |